147 related articles for article (PubMed ID: 19912736)
1. [Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial].
Huang JY; Sun Y; Fan QX; Zhang YQ
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1047-51. PubMed ID: 19912736
[TBL] [Abstract][Full Text] [Related]
2. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656
[TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer.
Lu P; Su W; Miao ZH; Niu HR; Liu J; Hua QL
Chin J Integr Med; 2008 Mar; 14(1):33-6. PubMed ID: 18219455
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].
Hu X; Jiao S; Zhang S; Wang Z; Wang M; Huang C; Zheng R; Li K; Wang J; Wang Y; Ouyang X; Lv W; Cheng G; Hu C; Luo R; Sun Y
Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):569-75. PubMed ID: 23075680
[TBL] [Abstract][Full Text] [Related]
5. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
Liu L; Wang XW; Li L; Zhang X; Zhang WD; Yu XJ
Ai Zheng; 2006 Aug; 25(8):990-4. PubMed ID: 16965680
[TBL] [Abstract][Full Text] [Related]
6. Improvement of quality of life with Shenfu injection in non small cell lung cancer patients treated with gemcitabine plus cisplatin regimen.
Wu WY; Long SQ; Zhang HB; Chai XS; Deng H; Xue XG; Wang B; Luo HY; Liu WS
Chin J Integr Med; 2006 Mar; 12(1):50-4. PubMed ID: 16571285
[TBL] [Abstract][Full Text] [Related]
7. [A prospective randomized controlled clinical trial of irinotecan plus cisplatin versus gemcitabine plus cisplatin as a first-line treatment for advanced non-small cell lung cancer].
Zhao WY; Chen DY
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):775-9. PubMed ID: 23291073
[TBL] [Abstract][Full Text] [Related]
8. [A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer].
Gao Y; Shi ZQ; Cao CW; Zhu CL; Guo J
Ai Zheng; 2005 Aug; 24(8):985-9. PubMed ID: 16086878
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
Duan J; Yang Z; Liu D; Shi Y
J BUON; 2018; 23(5):1402-1406. PubMed ID: 30570865
[TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
12. Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
Mok TS; Lam KC; Lee C; Zhang L; Wong H; Chan AT; Yeo W; Yim AP; Chak K; Zee B
Oncology; 2005; 68(4-6):485-92. PubMed ID: 16020979
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.
Kroep JR; Pinedo HM; Giaccone G; Van Bochove A; Peters GJ; Van Groeningen CJ
Ann Oncol; 2004 Feb; 15(2):230-5. PubMed ID: 14760114
[TBL] [Abstract][Full Text] [Related]
14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
de Castria TB; da Silva EM; Gois AF; Riera R
Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine combined with cisplatin vs. taxane, cisplatin, and fluorouracil in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective case-control study.
Huang YM; Qiao SQ; Lu L; Chen WP; Li SL; Qi CH
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7655-7663. PubMed ID: 32744691
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
Laack E; Dickgreber N; Müller T; Knuth A; Benk J; Lorenz C; Gieseler F; Dürk H; Engel-Riedel W; Dalhoff K; Kortsik C; Graeven U; Burk M; Dierlamm T; Welte T; Burkholder I; Edler L; Hossfeld DK;
J Clin Oncol; 2004 Jun; 22(12):2348-56. PubMed ID: 15197195
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.
Park K; Kim KP; Park S; Chang HM
Asia Pac J Clin Oncol; 2017 Feb; 13(1):13-20. PubMed ID: 27770489
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
Zhang Y; Chen L; Hu GQ; Zhang N; Zhu XD; Yang KY; Jin F; Shi M; Chen YP; Hu WH; Cheng ZB; Wang SY; Tian Y; Wang XC; Sun Y; Li JG; Li WF; Li YH; Tang LL; Mao YP; Zhou GQ; Sun R; Liu X; Guo R; Long GX; Liang SQ; Li L; Huang J; Long JH; Zang J; Liu QD; Zou L; Su QF; Zheng BM; Xiao Y; Guo Y; Han F; Mo HY; Lv JW; Du XJ; Xu C; Liu N; Li YQ; Chua MLK; Xie FY; Sun Y; Ma J
N Engl J Med; 2019 Sep; 381(12):1124-1135. PubMed ID: 31150573
[TBL] [Abstract][Full Text] [Related]
20. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
